Encore Dermatology Revenue and Competitors
Estimated Revenue & Valuation
- Encore Dermatology's estimated annual revenue is currently $502.5k per year.
- Encore Dermatology's estimated revenue per employee is $100,500
- Encore Dermatology's total funding is $76.7M.
Employee Data
- Encore Dermatology has 5 Employees.
- Encore Dermatology grew their employee count by -17% last year.
Encore Dermatology's People
| Name | Title | Email/Phone |
|---|
Encore Dermatology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Encore Dermatology?
Headquartered in Malvern, Pennsylvania, Encore Dermatology is a privately held fully integrated dermatology company with a mission committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients. Encore has a wide range of medical dermatology products, treating a number of topical disease states such as acne and atopic dermatitis. Encore Dermatology is rapidly expanding through acquisitions, in- licensing and co-marketing opportunities.
keywords:N/A
$76.7M
Total Funding
5
Number of Employees
$502.5k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Encore Dermatology News
... Bayer HealthCare, Encore Dermatology Inc., Meda Pharmaceuticals, Allergan Plc. (Republic of Ireland) and Bristol-Myers Squibb.
... Factors and How Companies are Responding Accordingly | Sanofi S.A., Encore Dermatology Inc, AbbieVie Inc., F. Hoffmann-La Roche AG,.
... AbbVie Inc., Encore Dermatology, Inc., Astellas Pharma Inc., Mylan N.V., AstraZeneca, 3M, and Teva Pharmaceutical Industries Ltd.
Encore Dermatology, Inc., a Malvern, Pennsylvania-based dermatologically-focused specialty pharmaceutical company, received a $20m venture loan facility from Horizon Technology Finance Corporation (NASDAQ: HRZN). $15m out of the total financing has been initially funded. The capital will enabl ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 5 | N/A | N/A |
#2 | $0.3M | 5 | N/A | N/A |
#3 | $0.5M | 5 | N/A | N/A |
#4 | $0.5M | 5 | N/A | N/A |
#5 | $0.5M | 5 | -17% | N/A |